Half of people stop taking popular weight-loss drug within a year, national study finds Dr. Kamal Kant Kohli22 Sept 2025 11:00 AM ISTThe new class of anti-obesity drugs, glucagon-like peptide-1 receptor agonists (GLP-1RAs), is proving remarkably effective at helping individuals lose...
EMA Committee approves update to Novo Nordisk Rybelsus label to reflect cardiovascular benefits Ruchika Sharma18 Sept 2025 3:39 PM ISTDenmark: Novo Nordisk has announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has approved...
Medical Bulletin 17/September/2025 Dr. Bhumika Maikhuri17 Sept 2025 3:00 PM ISTHere are the top medical news for the day:Your Thoughts Could Be Shrinking Your Brain: Study RevealsA new study published in BMC Psychiatry is drawing...
Enhanced Efficacy of High-Dose Semaglutide in Obesity and Type 2 Diabetes: STEP UP Trials Find Dr. Bhumika Maikhuri17 Sept 2025 8:15 AM ISTA higher weekly dose of semaglutide (7.2 mg) may offer a powerful new treatment for obesity, delivering significantly greater weight loss and health...
Higher Semaglutide Doses Safely Boost Weight Loss and Health in Adults with Obesity, Confirm Two Clinical Trials Dr. Kamal Kant Kohli16 Sept 2025 9:00 AM ISTA higher weekly dose of semaglutide (7.2 mg) can significantly improve weight loss and related health outcomes in adults living with obesity,...
Novo Nordisk Gets CDSCO Panel Nod for Rybelsus Label Update, Aligned with EMA Parthika Patel10 Sept 2025 9:36 PM ISTNew Delhi: The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organization (CDSCO) has recommended approval of an updated...
EMA warns of sharp rise in illegal medicines sold in EU Ruchika Sharma8 Sept 2025 2:18 PM ISTEuropean Medicines Agency (EMA) and the Heads of Medicines Agencies (HMA) are warning the public about the growing threat of illegal medicines being...
Virchow Biotech gets CDSCO panel nod to study Semaglutide for chronic weight management Susmita Roy7 Sept 2025 12:30 PM ISTNew Delhi: Recommending modifications in the protocol, the Subject Expert Committee (SEC), functional under the Central Drugs Standard Control...
Virchow Biotech Gets CDSCO Panel Nod for Semaglutide BE, Phase III Trials Parthika Patel6 Sept 2025 2:12 PM ISTNew Delhi: The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organization (CDSCO) has recommended granting permission to...
GLP-1 Receptor Agonists Improve Metabolic Outcomes in Schizophrenia Patients on Antipsychotics: JAMA Medha Baranwal6 Sept 2025 8:30 AM ISTDenmark: Researchers have found in a new randomized HISTORI trial that schizophrenia patients on antipsychotics experienced greater weight loss and...
Medical Bulletin 04/September/2025 Anshika Mishra4 Sept 2025 3:00 PM ISTHere are the top medical news for the day:Hepatitis B Vaccine May Lower Diabetes Risk: Study FindsA new study to be presented at the Annual Meeting of...
Weight Loss Drugs May Lower Risk of Heart Failure Hospitalization and Death by 40 Percent: Study Anshika Mishra4 Sept 2025 8:30 AM ISTA new large-scale study published in JAMA and presented at the European Society of Cardiology Congress reveals that glucagon-like peptide-1 (GLP-1)...
